New Key Statistics Module, Z-Score and F-Score
NAS:AKBA Key Ratios
Market Cap $ M | 253.61 |
Enterprise Value $ M | 281.86 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.25 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 194.00 |
EPS (TTM) $ | -0.28 |
Beneish M-Score | -2.79 |
10-y EBITDA Growth Rate % | 23.60 |
5-y EBITDA Growth Rate % | 59.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -6.23 |
EV-to-EBITDA | -83.22 |
PEG | -- |
Shares Outstanding M | 209.60 |
Net Margin (%) | -26.32 |
Operating Margin % | -23.32 |
Pre-tax Margin (%) | -26.32 |
Quick Ratio | 1.03 |
Current Ratio | 1.18 |
ROA % (ttm) | -18.80 |
ROE % (ttm) | -- |
ROIC % (ttm) | -21.84 |
Dividend Yield % | -- |
Altman Z-Score | -8.43 |
AKBA Number of Guru Trades
AKBA Volume of Guru Trades
Gurus Latest Trades with NAS:AKBA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AKBA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Akebia Therapeutics Inc Insider Transactions
No Available Data
News about NAS:AKBA
Total 0- 1